PrimeraDx's ICEPlex C. difficile Assay Kit Gets FDA Clearance
The ICEPlex c. difficile Assay Kit and the ICEPlex System from PrimeraDx have received FDA 510(k) clearance. The ICEPlex c. difficile Assay Kit is a molecular diagnostic test for the detection of Clostridium difficile in human stool samples.
The ICEPlex System is a quantitative multiplex PCR system with the unique ability to amplify and quantify multiple nucleic acid species of different types in a single reaction, starting from fresh, frozen or formalin-fixed paraffin-embedded samples. This makes it ideal for high-multiplex assays involving panels of such diverse analytes as mRNAs, microRNAs and genomic loci, and thus for the next generation of in vitro molecular diagnostics.
Tags: Clostridium difficile
Date Published: December 16, 2013 » company contact details
New Primer Pairs for LDTs for P. jirovecii, Group C and G Strep
FDA Clearance for ARIES C. difficile Assay Detecting both Toxin A and B
FDA Clearance for Solana® C. difficile Molecular Assay
Mobidiag, Molecular In Vitro Solutions for Syndromic Diagnostics
Baker Ruskinn Launches New Anaerobic and Microaerophilic Workstations